UnitedHealth Group discloses holdings changes to the SEC, while financial firms like Cantor Fitzgerald and Jefferies issue rating upgrades.
1 report, 1 independent
Updated Jun 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
UnitedHealth Group discloses holdings changes to the SEC, while financial firms like Cantor Fitzgerald and Jefferies issue rating upgrades.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- United Therapeutics filed Form 13F with the Securities and Exchange Commission.Sub-event
Analyst firms raised ratings and price targets for UnitedHealth Group following SEC filings.1 source
Keep exploring
The entities involved
-
UnitedHealth Group
for-profit health care company
-
Securities and Exchange Commission
government agency of the Philippines
- FDA completed mid-cycle review of INO-3107, and Inovio Pharmaceuticals announced the appointment of EY as its independent registered public accounting firm.
- Multiple major financial firms, including Jane Street, Grayscale Investments, Andreessen Horowitz, and Charles Schwab, submitted comments to the SEC regarding the review of ETFs.
Related events
- Datadog saw institutional investment changes tracked by the SEC and received a buy rating from TD Cowen.
- Dodge & Cox increased its share holdings in Comcast stock and filed disclosure regarding share purchases with the SEC on June 6, 2026.
- Colgate-Palmolive Company disclosed financial filings to the SEC, and CEO Noel Wallace sold company stock.
- Institutional investors increased their holdings in UnitedHealth Group stock, and the CEO sold company stock in a disclosed transaction.
- Multiple financial firms adjusted their holdings in UnitedHealth Group shares on October 14, 2026.